News Gilead to collaborate with Google’s Verily in inflammatory d... Gilead has signed a three-year deal with Google’s life science division Verily to work on identifying the immunological and molecular drivers behind three inflammatory diseases.
News FDA picks big tech and pharma for digital health fast-track Apple, Fitbit, Samsung and Verily join Johnson & Johnson and Roche in FDA Pre-Certification Pilot Program.
News Verily developing AI-based heart disease test Deep learning AI analyses retinal images to determine heart disease risk.
News Verily's Study Watch to feature in major PTSD trial Trial will enrol 5,000 people to determine causes of PTSD.
News Google’s Verily opens cancer testing lab Google’s life sciences arm Verily has opened a cancer testing lab for Freenome - a startup it invested in earlier this year.
Views & Analysis Digital health round-up: Apple's 'one-stop shop' Can Apple succeed where others can't?
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face